Clinical Trials Browser

Phase 3 × Lymphoma, Large B-Cell, Diffuse × orelabrutinib × Clear all

NCT05234684 2024-02-07

BELIEVE-01

Phase 3 Unknown

Lymphoma, Large B-Cell, Diffuse

NCT05351346 2023-03-24

Genotype-guided Treatment in DLBCL

Phase 3 Recruiting

Lymphoma, Large B-Cell, Diffuse